EXECUTIVE COMMITTEE

Chair: Edward J. Schutter; Executive Officer Roundtable & Summit Chair, GaBio; President and Chief Executive Officer, Arbor Pharmaceuticals

Charles Craig; President, Georgia Bio

Patricia A. Fritz MS RAC; Vice President, Policy and Communication, UCB, Inc.

Ross Mason; Founder, Healthcare Institute for Neuro-Recovery and Innovation (HINRI), Georgia

Margaret Poole; Chief Executive Officer, Informed Horizons

John "JJ" Spegele; Vice President, General Manager, Quintiles Laboratories North America

Maria Thacker; Director of Operations, Georgia Bio

PROGRAM COMMITTEE

Chair: John “JJ” Spegele; Vice President, General Manager, Quintiles Laboratories North & South America

Clay Fowler; Peach Seed Capital

Mark Gilreath; President and Chief Executive Officer, EndoChoice Inc.

Mark W. Hamrick; Interim Vice President for Research, Professor Department of Cellular Biology & Anatomy, Georgia Health Sciences University

Michael R. Hanley, Ph.D.; Chief Executive Officer, Celtaxsys, Inc

Barney Koszalka, PhD; President/Chief Executive Officer, NeurOp, Inc.

Dan Myers; President and Chief Executive Officer, Alimera Sciences, Inc

Robin Morris, Ph.D.; Associate Provost for Strategic Initiatives & Innovation, Georgia State University

Ed Perkins; Johnson & Johnson

Anthony J. Rotunno, Sr.; Vice President & General Manager, Dendreon Corporation

Suzanne S. Shope, J.D.; Technology Licensing and Marketing Scientist, Centers for Disease Control and Prevention

William “Bill” C. Taylor; President and Chief Operating Officer, MiMedx Group, Inc.

Andrew Watkins, JD, PhD; Director, Technology Transfer Office, Centers for Disease Control and Prevention